As of 2025-05-16, the Fair Value of vTv Therapeutics Inc (VTVT) is -28.94 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 22.41 USD, the upside of vTv Therapeutics Inc is -229.13%.
With the market price of 22.41 USD and our fair value calculation, vTv Therapeutics Inc (VTVT) is not a good investment. Investing in VTVT stocks now will result in a potential loss of 229.13%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -8.50 | -12.99 | -19.16 | -20.25 | -18.46 | -15.87 |
| YoY growth | 34.82% | -52.82% | -47.50% | -5.69% | 8.83% | -12.47% |
| Market Cap (mil) | 71.49 |
| P/E | |
| Forward P/E |
| EPS | -5.79 |
| Avg earnings growth rate | -12.47% |
| TTM earnings | -18.46 |